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Mixtures of creatinlne, glucose and various single amino acids
were heated at 180°C for 10 min in an aqueous model system.
The heated mixtures all showed mutagenic activity, ranging
from 80 to 2400 TA98 revertant colonies/ujnol creatinine with
metabolic activation. Testing of HPLC fractions for mutagenic
activity showed each mixture to contain several mutagenic
components, some of which corresponded to known hetero-
cyclic amines and others to unknown compounds. The
presence of 2-amlno-3-methyl-irnidazo[4,5-/|quinoxaline, 2-
amino-3$-dimethylimidazo[4,5-/|quinoxaline and 2-amino-
3,7,8-trimethylimid^zo[4,5-/|quinoxaline in most of the
samples was established using HPLC with photodiode array
detection and liquid chromatography/mass spectrometry with
electrospray interface and single ion monitoring. In addition,
2-amino-3,4,8-trimethyllniidazo[4,5-/]quinoxaline, 2-amino-
l-methyl-6-phenylimidazo[4,5-6]pyridine, 3-amlno-l,4-di-
methyl-5//-pyrido[4,3-fc]indole and 3-amino-l-methyI-5ff-
pyrido[4,3-*]indole and the co-mutagenic compounds 9H-
pyrido[3,4-*]indole and l-methyl-9H-pyrido[3,4-*]indole
were detected in some samples.
Introduction
The major food mutagens isolated to date from cooked meat
and fish products are heterocyclic amines (HAs*). Since first
reported by Sugimura et al. (1), much effort has been devoted
to identifying and quantifying these compounds and to under-
standing the mechanisms of their formation (for reviews see
2,3). Most of the mutagenic heterocyclic amines formed
at normal cooking temperatures are imidazoquinolines or
imidazoquinoxalines (IQ compounds), imidazopyridines (e.g.
2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine; PhIP) or
imidazofuropyridines (4-6).
Many HAs are multipotent carcinogens in long-term rodent
bioassays (for a review see 7), with 2-amino-3-methylimid-
•Abbreviations: HA(s), heterocyclic amine(s); PhIP, 2-amino-1 -methyl-6-
phenylimidazo[4,5-6)pyridine; IQ, 2-amino-3-methylimidazo|4,5-/]quinoline;
IQx, 2-amino-3-methylimidazo[4,5-/lquinoxaline; MelQ, 2-anuno-3,4-
dimethylimidazo[4,5-./]quinoline; MelQx, 2-amino-3,8-dimethylimidazo[4,5-
/Iquinoxaline; 4,8-DiMeIQx, 2-amino-3,4,8-trimethylimidazo[4,5-/]quinox-
aline; LC/MS, liquid chromatography/mass spectrometry; 7,8-DiMeIQx, 2-
amino-3,7,8-trimethylimidazo[4,5-/|quinoxaline; Glu-P-1, 2-amino-6-methyl-
dipyrido[l,2-a:3',2'-rf|imidazole; Glu-P-2, 2-aminodipyrido[l,2-<i:3',2'-<]
imidazole; Trp-P-1, 3-amino-l,4-dimethyl-5//-pyrido[4,3-b]indole; Trp-P-2,
3-amino-l-methyl-5//-pyrido[4,3-fc]indole; harman, l-methyl-9//-pyrido[3,4-
6]indole; norharman, 9H-pyrido[3,4-i]indole.
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azo[4,5-/]quinoline (IQ) also positive in primates (8). Epidemi-
ological studies have shown a relationship between the
consumption of fried meat products and an elevated risk of
colon and other cancers (9-13). The HAs are animal carcino-
gens and the IARC classified several of them as possible or
probable (IQ) human carcinogens (14-16). Efforts to minimize
their formation in cooked foods are therefore of great impor-
tance and a better understanding of the formation mechanism
is needed. Simple modelling experiments have been useful in
providing basic information on precursors, inhibitors and the
effect of reaction conditions and a good correlation between
the formation of HAs in cooked foods and model systems has
been observed (for reviews see 3,17).
All details of the formation mechanism of HAs have not
yet been clarified. Jagerstad et al. (18) suggested that IQ
compounds may be produced via the Maillard reaction from
creatin(in)e, amino acids and hexoses present in foods of
animal origin (see Scheme 1). This hypothesis has been
confirmed by heating creatin(in)e, amino acids and sugars in
various model systems, resulting in the formation of IQ, 2-
amino-3-methylimidazo[4,5-/lquinoxa]ine (IQx), 2-amino-3,4-
dimethylimidazo[4,5-/lquinoline (MelQ), 2-amino-3,8-dimethyl-
imidazo[4,5-/]quinoxaline (MelQx), 2-amino-3,4,8-trimethyli-
midazo[4,5-/|quinoxaline (4,8-DiMeIQx) and PhIP (for
reviews see 3,19). Also, l4C-labelled glucose was shown to
be incorporated into IQx, MelQx and 4,8-DiMeIQx using an
aqueous model system (20). Alternative routes for the formation
of HAs may exist, since their formation from creatin(in)e and
amino acids has also been observed in the absence of sugar
in dry heating model experiments. However, the yield of HAs
in the absence of sugar is usually lower (for a review see 3).
According to the hypothesis illustrated in Scheme 1, amino
acids act as precursors of HAs partly by serving as a nitrogen
source in pyridine or pyrazine formation (18). However,
mutagenic activity and HA yield previously reported in model
systems vary depending on the particular amino acid used (for
reviews see 3,17). These variations were not completely
explained and, so far, the ability to produce mutagenic activity
in a model system has been investigated for less than half the
naturally occurring amino acids, and even fewer amino acids
have been tested as precursors of HAs.
This study was performed to further investigate the effect
of various amino acids on the yield and nature of HAs formed
in a model system and to increase the understanding of the
reactions behind the formation of HAs. Model mixtures, each
containing creatinine, glucose and one of the most common
amino acids, were heated at 180°C for 10 min. The heated
mixtures were tested for mutagenic activity using Salmonella
typhimurium TA98 with metabolic activation. Furthermore, the
model mixtures were purified using the propylsulphonic acid-
silica gel tandem extraction method (21) and analysed for
known HAs using HPLC wkh a photodiode array and fluores-
cence detection and liquid chromatography/mass spectrometry
(LC/MS) with electrospray ionization and single ion mon-
itoring. The HPLC fractions were tested for mutagenic activity.
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Scheme 1. Suggested pathway for the formation of imidazoqumolines and imidazoquinoxalines (18).
Materials and methods
Chemicals
AJI chemicals and solvents were of HPLC or analytical grade. The solvents,
e.g. acetonitrile, methanol and dichloromethane, were purchased from Merck
AG (Darmstadt, Germany). Water was obtained from a Milli-Q water purifica-
tion system (Millipore, Bedford, MA). Creatinine and amino acids were
obtained from Sigma Chemical Co. (St Louis, MO) and glucose from BDH
Chemicals Ltd (Dorset, UK). Synthetic IQ, IQx, MelQ, MelQx, 4,8-DiMeIQx,
2-amino-3,7,8-trimethylimidazo[4,5-/]quinoxa]ine (7,8-DiMeIQx), PhIP, 2-
amino-6-methyl-dipyrido[l,2-a:3',2'-rf]imidazole (Glu-P-1), 2-aminodipyr-
ido[l,2-a:3',2'-<flimidazole (Glu-P-2), 3-amino-l,4-dimethyl-5//-pyrido[4,3-
b]indole (Trp-P-1), 3-amuio-l-rnethyl-5//-pyrido[4,3-6]indole (Trp-P-2) and 1-
methyl-9//-pyrido[3,4-i>]indole (harman) were obtained from Toronto Research
Chemicals (Downsview, Ontario, Canada) and 9//-pyrido[3,4-6]indole (norhar-
man) from Aldrich (Steinheim, Germany). The materials used for propylsulph-
onic acid-silica gel tandem extraction (Extrelut and BondElut, e.g. PRS and
C]g) were obtained from Merck AG (Darmstadt, Germany) and Analytichem
International (Sorbent, Vastra FrOlunda, Sweden).
Sample preparation
Samples were prepared by heating creatinine, glucose and various amino acids
in an aqueous model system as previously described (22). In brief, creatinine
(0.9 mmol), glucose (0.45 mmol) and either (0.9 mmol) glycine, alanine,
valine, leucine, isoleucine, serine, threonine, aspartic acid, asparagine, glutamic
acid, glutamine, lysine, arginine, histidine, phenylalanine, tyrosine, tryptophan,
cysteine, cystine, methionine, proline or hydroxyproline were dissolved in 2.5
ml water and heated for 10 min at 180°C in sealed test tubes. A blank sample
(without any amino acid) was prepared concurrently.
After heating the samples were purified using the solid phase extraction
method of Gross (21) with some minor modifications (22). Using this method
a polar extract (containing the IQ-type HAs and glutamic acid pyrolysates)
and a non-polar extract (containing pyridoindoles) were obtained. Only the
polar extract was analysed for HAs in this study.
HPLC fractionation for mutagenic activity profiles
Extract residues obtained after purification were dissolved in 250 (il HPLC
buffer A (see below) and aliquots (30 u.1) w e r e injected (Varian 9100
Autosampler) into a Varian 9010 Liquid Chromatograph with a photodiode
array UV detector (Varian 9065, Polychrom) equipped with a ToyoSoda TSK
Gel ODS 80TM column (250X4.6 mm i.d., 5 nm particle size; Varian,
Stockholm, Sweden) and a pre-column (Supelguard LC-18-DB, 20X4.6 mm
i.d.) and eluted with a mobile phase of 10 mM aqueous triethylamine adjusted
with acetic acid to pH 3.2 (A) or pH 3.6 (B) and acetonitrile (C). A gradient
of 5-15% C in A for 10 min, then 15-25% C in B for 10 min and finally
25-55% C in B for 5 min was used. The flow rate was 1 ml/min and the
effluent was monitored at 263 nm. Fractions were collected every 30 s between
8 and 30 min and lyophilized before assaying for mutagenic activity.
Table I. Mutagenic activity of model mixtures containing creatinine,
glucose and various amino acids heated at 180°C for 10 min
Amino acid Mutagenic activity1
Cysteine
Cystine
Threonine
Lysine
Serine
Alanine
Histidine
Asparagine
Tyrosine
Arginine
Glutamine
Glycine
Aspartic acid
Methionine
Isoleucine
Proline
Valine
Leucine
Hydroxyproline
Tryptophan
Glutamic acid
Phenylalanine
2420
2251
796
556
483
478
439
432
322
314
306
290
271
262
261
240
240
198
177
102
92
83
*TA98 revertants/(imol creatinine, with metabolic activation from the linear
portion of dose-response curves from replicate platings.
Mutation assay
The mutagenic activity of the lyophilized HPLC fractions was tested as
described by Ames et al. (23) using Salmonella strain TA 98 with the addition
of 0.5 ml S9 mix containing 5% chlorophene-induced rat liver/plate (24). The
fractions were tested at single doses. Crude heated model mixtures were tested
in duplicate at three different doses to establish dose-response curves. The
number of revertants/nmol original creatinine was calculated from the linear
part of the curve (25). Synthetic MelQx was used as a positive control (50 000
revertants/jlg). The colonies were counted in an automated colony counter
using the software Cream™ (Kem-En-Tec, Copenhagen, Denmark). The
spontaneous reversion rate was 30-35 revertants/plate. A fraction or sample
was considered mutagenic if it induced revertants to twice the background level.
Identification and quantification of HAs using HPLC
The HAs extracted from the heated model systems were identified and
quantified by HPLC employing a Hewlett Packard 1090M system containing
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Figure 1. Mutagenic activity in TA98 with metabolic activation in fractions from HPLC separation of heated model mixtures containing various amino acids.
Mutagens corresponding to the retention times of HAs are indicated. Retention times of synthetic HAs are: Glu-P-2, 11.3 min; IQ, 11.6 min; IQx, 11.8 min;
MelQ, 14.3 min; MelQx, 15.1 min; Glu-P-1, 15.3 min; 7,8-DiMeIQx, 17.2 min; 4,8-DiMeIQx, 18.3 min; norharman, 21.1 min; harman, 23.1 min; Trp-P-2,
25.9 min; PhIP, 26.4 min; Trp-P-1, 27.3 min. Retention times of HAs differed due to the complexity of the sample.
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Figure 2. Expanded region of a UV chromatogram (wavelength 263 nm) from HPLC analysis of a heated model mixture containing tyrosine. Peaks
corresponding to known HAs are indicated. On-line recorded UV spectra compared with those of synthetic IQx, MelQx and 7,8-DiMeIQx.
a photodiode array and a time programmable fluorescence detector (HP
1046A) connected in series. Chromatographic conditions were as above. UV
detection was performed at 263 nm while excitation/emission wavelengths
were 360/450 nm for Glu-P-1 and Glu-P-2, 300/440 nm for harman and
norharman, 265/410 nm for Trp-P-1 and Trp-P-2 and 315/390 nm for PhlP.
Aliquots of 10 nl from 200 nl of the purified samples were injected.
HAs were identified by comparing the retention times of the peaks with
those of synthetic compounds, namely IQ, IQx, MelQ, MelQx, 4,8-DiMeIQx,
7,8-DiMeIQx, PhJP, Glu-P-1, Glu-P-2, Trp-P-1, Trp-P-2, norharman and
harman, obtained under the same conditions. In addition, some extracts were
also spiked with synthetic compounds before injection. UV spectra of synthetic
compounds obtained under the same conditions, together with literature data,
were used to confirm the identities of the HAs.
The amounts of HAs were estimated by comparing the HPLC peak area of
the chromatographed sample with that of a known amount of standard. The
amounts were not corrected for incomplete extraction recovery.
LC/MS analysis of HAs
HPLC was performed with a Waters 600-MS pump, a Waters 490-MS UV
detector and a Waters 717 autosampler injecting 20 ul of the sample. The
column was a ToyoSoda TSK Gel ODS 80TM (250X4.6 mm i.d., 5 nm
particle size), protected with a pre-column containing the same stationary
phase. The mobile phases were as follows: solvent A, 10 mM ammonium
acetate adjusted with HC1 to pH 3.2; solvent B, 10 mM ammonium acetate
adjusted with HC1 to pH 4.0; solvent C, acetonitrile. The linear gradient
program was as follows: 0-10 min, 5-17% C in A; 10-10.1 min exchange of
buffer B for A; 10.1-22 min, 17-55% C in B; 22-25 min, 55-90% C in B.
The flow rate was 1 ml/min and 50% of the flow was split off before entering
the mass spectrometer. MS was performed with a Finnigan TSQ-700 mass
spectrometer (Bremen, Germany) equipped with a Finnigan electrospray
interface working at the high voltage of 4.5 kV. The manifold temperature
was 70°C and the heated capillary was set at 250°C. Nitrogen was used as
sheath gas at a pressure of 4.8 bar. The compounds were detected after
monitoring the protonated molecular ions [M + H]+ .
Results
Formation of mutagenic activity in model mixtures
The heated model mixtures all showed mutagenic activity in
Salmonella typhimurium TA98 with metabolic activation, as
shown in Table I. The mutagenic activity ranged from 80 to
2400 revertants/(i.mol creatinine. Mixtures containing cysteine,
cystine or threonine showed the highest response, while the
lowest was found in mixtures containing tryptophan, glutamic
acid or phenylalanine. No detectable mutagenic activity was
formed in the blank sample.
HPLC fractions were tested for mutagenic activity to deter-
mine the number of mutagenic compounds and to compare
the elution times of the mutagenic components with those of
known HAs. Figure 1 shows the mutagenic activity profiles
for heated samples containing different amino acids. Each
profile contained two to seven mutagenic peaks, some of which
elute at similar retention times to those of known HAs found
in the pyrolysis products of foods. The mutagenic compounds
co-eluting with known HAs are indicated in Figure 1.
Identification of mutagenic compounds
By comparing the retention times of the mutagenic peaks with
those of known HAs and by using HPLC UV spectrometry
and LC/MS analysis, the presence of several known HAs in
the various model systems was established. Figures 2 and 3
show chromatograms obtained from a heated model sample
containing tyrosine from HPLC and LC/MS analyses respect-
2556
Influence of amino adds on HA formation
A
100,
50
1«fr
100
so
100
60
100
60-
100
60
100-
60
100
60
100
60
100!
60
Olu-P-2
tQ du-P-1
HoJQ
E+06
3.723
E+O«
1.093
E+06
HeKtx
7,6-dllMQx
4,8-dUUKht
AoC
Trp-P-2
nVz:1M
BoAaC
A
E+08
1.704
E+oe
2.613
E+O8
1.328
E+O8
1224
E+Of
2.626
E+O8
Trp-P-1 E+063.764
E+06
3.426
10*0 13:20 16:40 20:00 23:20 26:40 30:00
Ratantton dm* (mdn)
B
100
10O
6a
100-
60
100
60
m/z:200
mfc214
« * .
nWz:22a
! f
MatQx
I f
PhIP
7,8-dHMQjl
E+06
1.0*8
E+06
1.936
E+03
3.184
E+04
1.803
1ChOO 13:20 16:40 2040 23:20
Ratantion dim (mln)
Figure 3. LC7MS analysis of a model system. (A) Selected ion monitoring
of reference HAs at the respective mJz [M+H]+ ions. (B) Analysis of a
sample containing tyrosine. The chromatogram displays the expanded region
containing IQx, MelQx, PhIP and 7,8-DiMeIQx (shadowed).
ively. A comparision of UV absorption spectra of the tyrosine
sample and those of synthetic references is also shown in
Figure 2. As shown in Table II, IQx, MelQx and 7,8-DiMeIQx
were present in most of the heated model mixtures. In addition,
4,8-DiMeIQx was detected in samples containing alanine,
threonine, lysine, phenylalanine or methionine. We failed to
confirm the presence of IQx with LC/MS in some samples,
due to unstable signals (Table II). Norharman and harman
were formed in samples containing isoleucine, arginine, phenyl-
Table II. Estimated amounts (jimol/mol creatinine) of IQx, MelQx and 7,8-
DiMeIQx formed in heated mixtures of glucose, creatinine and amino acids
analysed using HPLC with photodiode array detection
Amino acid IQx MelQx 7,8-DiMeIQx
Glycine
Alanine
Valine
Leucine
Isoleucine
Serine
Threonine
Aspartic acid
Asparagine
Glutamine
Lysine
Arginine
Histidine
Phenylalanine
Tyrosine
Tryptophan
Cysteine
Cystine
Methionine
Proline
3.1 ± 0.8
5.0"
c
c"
c
6.5*
4.5'
c"
2.9s
1.4
c"
3.7 ± 0.3
1.8
1.5 ± 0.3
2.6 ± 2.3
0.7
0.1
0.9*
3.6 ± 1.2
5.4 ± 5.1
4.7 ± 3.5
2.4
2.7 ± 0.7
3.0 ± 1.7
9.2 ± 2.1
0.8 ± 0.6
1.5
0.6
7.7 ± 3.7
4.1 ± 0.7
3.4 ± 3.2
1.9 ± 0.7
3.6 ± 2.1
5.0 ± 3.5
c
c
2.7 ± 0.5
0.3
0.7
cb
c
c
0.1
c
0.2
c
c
ca
c*
0.1
c
c
c
c '
"Not detected using LC/MS.
bc, co-eluting compounds interfered with peak area determination.
Amounts are means from the analysis of duplicate samples. LC/MS with
electrospray interface and single ion monitoring was used for the detection
of the compounds.
alanine or tryptophan. Norharman was also formed in a model
mixture with tyrosine. PhIP was found in model mixtures
containing phenylalanine, isoleucine or tyrosine. Trp-P-1 and
Trp-P-2 were found in a model mixture containing tryptophan.
Trp-P-1 was also detected in the isoleucine sample. IQ, MelQ,
Glu-P-1 and Glu-P-2 were not found in any of the samples.
No known HAs were found in the glutamic acid and hydroxy-
proline samples or in the blank sample. However, several
unknown mutagenic components were present in the heated
samples.
Quantification of HAs
The amounts of HAs in the samples were estimated from the
UV and fluorescence chromatograms and are shown in Table
II for IQx, MelQx and 7,8-DiMeIQx; their maximum yields
were 6.5, 9.2 ± 2.1 and 0.7 umol/mol creatinine respectively.
Samples containing arginine, glycine or tyrosine produced
large amounts of IQx. Most MelQx was formed in the sample
containing threonine, followed by samples containing lysine,
tryptophan and alanine. The alanine-containing sample pro-
duced 1.1 (jjnol 4,8-DiMeIQx/mol creatinine, while 7.3 ± 4.2
(xmol PhlP/mol creatinine were produced in the phenylalanine-
containing sample. Due to co-eluting compounds, it was
impossible to estimate the amounts of HAs, especially 7,8-
DiMeIQx and 4,8-DiMeIQx, in some of the samples. The
amounts of norharman, harman, Trp-P-1 and Trp-P-2 were not
determined. The amounts of HAs given in Table II are not
corrected for incomplete extraction recovery. Extraction of
similar model mixtures gave a recovery of 52-97% for
MelQx (19,22).
Discussion
The hypothesis for the formation of IQ compounds in Scheme
1 postulated that creatine forms the 2-aminoimidazo part by
cyclization and dehydration. The quinoline/quinoxaline part of
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the molecule arises from pyridines or pyrazines and Strecker
aldehydes, formed in the Maillard reaction (18). Surprisingly,
neither IQ nor MelQ was found in any of the samples. This
implies mat no pyridines are formed in die model system. IQ
and MelQ have previously been detected in model systems
with fructose (26,27) and in dry heating experiments (for a
review see 3).
Amino acids act as precursors of HAs by serving as a
nitrogen source in pyrazine formation (28). They also seem to
provide the carbon and, in some cases, the methyl group at
position 4 (18). According to the hypothesis, glycine is a
precursor of IQ, MelQx and 7,8-DiMeIQx, while alanine might
give MelQ and 4,8-DiMeIQx. However, in this study IQx,
MelQx and 7,8-DiMeIQx were formed from most amino acids,
including alanine, when heated with glucose and creatinine in
the model system. Moreover, 4,8-DiMeIQx was formed not
only from alanine, but also from threonine, lysine, phenylalan-
ine and methionine.
Some of these results are hard to reconcile with the hypo-
thesis illustrated in Scheme 1. However, several amino acids
are derivatives of alanine carrying an electropositive group
(E), e.g. a heteroatom with a free electron pair or an aromatic
ring with TI electrons. These amino acids, e.g. serine, threonine,
cysteine, cystine, phenylalanine, tyrosine, tryptophan and histi-
dine, might undergo retroaldolization to glycine,
NH3
H-E-CH 2 - CH -
NH3
= CH2" + CH 2-CO 2 '
thereby explaining the formation of IQx, MelQx and 7,8-
DiMeIQx. The other retroaldolization product (E = CH2) of
threonine is acetaldehyde, which could explain the formation
of 4,8-DiMeIQx from threonine. Less reactive retroaldolization
products are expected from aromatic amino acids. This might
explain why IQx compounds with an aryl group at position 4
have never been observed. It is more difficult to guess which
reactions valine, leucine, isoleucine, methionine, asparagine,
glutamine, aspartic acid, glutamic acid, proline and hydroxy-
proline undergo in the model system. One possibility might
be that these molecules fragment through free radical reactions.
Clearly, the observed IQx compounds do not always fit the
hypothesis in Scheme 1 and other reaction pathways cannot
be excluded. The divergence might be explained by the
preferred formation of other HAs, such as PhIP from phenylal-
anine and Trp-P-1 and Trp-P-2 from tryptophan.
Pyrazines arise through cyclodimerization of aminodeoxy
sugars, formed from a-dicarbonyl compounds and amino acids
in the Strecker degradation (29). The yield and species of
pyrazines vary with the amino acid (28, 30-33). Sugars are
known to fragment through retroaldol or related reactions. If
fragmentation precedes pyrazine formation, glyoxal, methyl-
glyoxal and/or biacetyl serve as a-dicarbonyl sources. Methyl-
glyoxal is the most common source, giving rise to 2,5-
dimethylpyrazine, which is die precursor of MelQx and 4,8-
DiMeIQx. If glyoxal and methylglyoxal co-dimerize, methyl-
pyrazine, which is the precursor of IQx, is formed. If methyl-
glyoxal and biacetyl co-dimerize, trimethylpyrazine, which is
the precursor of 7,8-DiMeIQx, is obtained. Consequently, a
mixture of glyoxal, methylglyoxal and biacetyl may have been
present in our model mixtures, thus giving rise to IQx, MelQx,
4,8-DiMeIQx and 7,8-DiMeIQx. However, the methylpyraz-
ines may also have formed through initial cyclodimerization,
Table ni . Literature data on heterocyclic amines in i
amino acids and creatin(in)e with and without sugar
Amino
acid
Gly
Ala
Leu
Ser
Thr
Lys
Tyr
Phe
Pro
Sugar
Fru
Glc
Glc
Fru
Glc
Glc
Glc
Glc
Glc
Glc
Glc
Fru
Glc
Rib
-
Fru
Glc
Rib
-
-
-
-
Glc
Glc
Glc
Glc
Glc
Rib
Rib
-
-
Glc
Glc
Glc
Glc
-
Glc
-
Glc
-
-
HA
IQ
IQx
MelQx
MelQx
MelQx
MelQx
MelQx
4,8-DiMeIQx
4,8-DiMeIQx
7,8-DiMeIQx
7,8-DiMeIQx
MelQ
MelQ
MelQ
MelQ
4,8-DiMeIQx
4,8-DiMeIQx
4,8-DiMeIQx
PhIP
IQ
IQx
MelQx
IQx
MelQx
MelQx
4,8-DiMeIQx
4,8-DiMeIQx
MelQx
4,8-DiMeIQx
MelQx
IQ
IQ
MelQx
4,8-DiMeIQx
PhIP
PhIP
PhIP
PhIP
PhIP
PhIP
IQ
Yield1
1.0
nd
4.4
6-7
4
8.8-17.9
7-10
nd
nd
1.1
nd
nd
0.9
1.8
nd
1.9-2.6
4.2
1.5
nd
3.7
2.7
nd
nd
nd
9
nd
30
4.2
26.1
nd
3.0
13.5
nd
nd
3.6
735
560
nd
20.9
6.4
0.4
nodel systems
Model
system2
reflux
H2O
reflux
reflux
DEG
H2O
H2O
DEG
H2O
reflux
DEG
reflux
reflux
reflux
dry
reflux
reflux
reflux
dry
dry
dry
dry
H2O
reflux
H2O
reflux
H2O
reflux
reflux
dry
dry
dry
DEG
DEG
reflux
dry
dry
dry
DEG
DEG
dry
from
Ref. no.
(27)
(22)
(38)
(27)
(35)
(19)
(20)
(35)
(19)
(39)
(35)
(26)
(40)
(40)
(34)
(26)
(40)
(40)
(34)
(41)
(41)
(34)
(20)
(42)
(20)
(42)
(20)
(40)
(40)
(34)
(43)
(43)
(44)
(44)
(45)
(42)
(42)
(34)
(44)
(44)
(46)
'Yield in nmol/mmol creatin(in)e.
nd = Not determined.
2Reflux = reflux-boiling in diethylene glycol/water (5:1) at 125-128°C for
2 h; H2O = heated in H2O in sealed test-tubes at 180°C for 10 min;
DEG = heated in deithylene glycol/water (5:1) at 180°C for 10 min;
dry = dry heating at 180°C for 1 h.
followed by fragmentation of the pyrazine substituents.
All amino acids tested produced mutagenic activity to a
varying extent when heated with creatinine and glucose in a
model system. The mutagenic activity was generally higher
than reported earlier. When various amino acids, creatine and
glucose were boiled under reflux in aqueous diethylene glycol
for 2 h at 128CC only samples containing threonine, glycine
or lysine produced mutagenic activity exceeding 200 TA98
revertants/nmol creatine (18). Mixtures containing cysteine
and cystine, which produced the highest mutagenic activity in
the present study, only showed weak mutagenic activity in our
previous study. One explanation might be that a closed model
system was used in the present study, preventing volatile
intermediates from vaporizing. In another study by Overvik
et al. (34) various amino acids produced much lower mutagenic
activity after dry heating (1 h at 200°C) with creatine in the
absence of sugar. In that study samples with serine or threonine
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showed the highest mutagenic activity. However, serine and
threonine are known to decarboxylate and produce pyrazines
through dimerization when heated (29).
Comparing our results with previous studies on the formation
of HAs in model systems containing various amino acids (see
Table HI) shows both similarities and differences. However,
different kinds of model systems have been used, e.g. dry
heating at 180°C for 2 h, reflux boiling in diethylene glycol/
water at 125-128°C for 2 h, heating in diethylene glycol/water
at 180°C for 10 min in open test tubes and heating in water
at 180°C for 10 min in sealed test tubes.
To our knowledge, this is the first study reporting the
formation of IQx and 7,8-DiMeIQx from most amino acids
tested (for a review see 3). In addition, several unknown
mutagenic components were present in the heated samples.
New mutagenic compounds have been first identifed in model
systems and later identified in cooked foods (35-37). Much
still remains to be done before the complex reaction mechan-
isms behind the formation of HAs is totally elucidated and the
unknown mutagenic compounds are identified.
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